These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 20595634)
1. Synuclein gamma stimulates membrane-initiated estrogen signaling by chaperoning estrogen receptor (ER)-alpha36, a variant of ER-alpha. Shi YE; Chen Y; Dackour R; Potters L; Wang S; Ding Q; Wang Z; Liu YE Am J Pathol; 2010 Aug; 177(2):964-73. PubMed ID: 20595634 [TBL] [Abstract][Full Text] [Related]
2. ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways. Lin SL; Yan LY; Zhang XT; Yuan J; Li M; Qiao J; Wang ZY; Sun QY PLoS One; 2010 Feb; 5(2):e9013. PubMed ID: 20126312 [TBL] [Abstract][Full Text] [Related]
3. Gamma synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor alpha signaling and mammary tumorigenesis. Jiang Y; Liu YE; Goldberg ID; Shi YE Cancer Res; 2004 Jul; 64(13):4539-46. PubMed ID: 15231664 [TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor-α variant, ER-α36, is involved in tamoxifen resistance and estrogen hypersensitivity. Zhang X; Wang ZY Endocrinology; 2013 Jun; 154(6):1990-8. PubMed ID: 23546601 [TBL] [Abstract][Full Text] [Related]
5. ER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway. Tong JS; Zhang QH; Wang ZB; Li S; Yang CR; Fu XQ; Hou Y; Wang ZY; Sheng J; Sun QY PLoS One; 2010 Nov; 5(11):e15408. PubMed ID: 21079811 [TBL] [Abstract][Full Text] [Related]
6. Chaperoning of estrogen receptor and induction of mammary gland proliferation by neuronal protein synuclein gamma. Liu YE; Pu W; Jiang Y; Shi D; Dackour R; Shi YE Oncogene; 2007 Mar; 26(14):2115-25. PubMed ID: 17016445 [TBL] [Abstract][Full Text] [Related]
7. ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway. Zhu L; Zou J; Zhao Y; Jiang X; Wang Y; Wang X; Chen B J Exp Clin Cancer Res; 2018 Jun; 37(1):123. PubMed ID: 29940998 [TBL] [Abstract][Full Text] [Related]
8. Synuclein gamma protects HER2 and renders resistance to Hsp90 disruption. Shao Y; Wang B; Shi D; Miao S; Manivel P; Krishna R; Chen Y; Eric Shi Y Mol Oncol; 2014 Dec; 8(8):1521-31. PubMed ID: 24998446 [TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor alpha-36 (ER-α36): A new player in human breast cancer. Wang ZY; Yin L Mol Cell Endocrinol; 2015 Dec; 418 Pt 3():193-206. PubMed ID: 25917453 [TBL] [Abstract][Full Text] [Related]
10. Synuclein γ protects Akt and mTOR and renders tumor resistance to Hsp90 disruption. Liang W; Miao S; Zhang B; He S; Shou C; Manivel P; Krishna R; Chen Y; Shi YE Oncogene; 2015 Apr; 34(18):2398-405. PubMed ID: 24954510 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of estrogen receptor signaling by gamma synuclein. Jiang Y; Liu YE; Lu A; Gupta A; Goldberg ID; Liu J; Shi YE Cancer Res; 2003 Jul; 63(14):3899-903. PubMed ID: 12873981 [TBL] [Abstract][Full Text] [Related]
12. A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Wang Z; Zhang X; Shen P; Loggie BW; Chang Y; Deuel TF Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9063-8. PubMed ID: 16754886 [TBL] [Abstract][Full Text] [Related]
13. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro. Gu W; Dong N; Wang P; Shi C; Yang J; Wang J Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347 [TBL] [Abstract][Full Text] [Related]
14. Structural insights into tumor-specific chaperoning activity of gamma synuclein in protecting estrogen receptor alpha 36 and its role in tamoxifen resistance in breast cancer. Panneerselvam M; Muthu K; Ramadas K Mol Biosyst; 2015 Nov; 11(11):2998-3010. PubMed ID: 26299756 [TBL] [Abstract][Full Text] [Related]
15. Estrogen activation of the mitogen-activated protein kinase is mediated by ER-α36 in ER-positive breast cancer cells. Zhang X; Deng H; Wang ZY J Steroid Biochem Mol Biol; 2014 Sep; 143():434-43. PubMed ID: 24973581 [TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor variant ER-α36 promotes tamoxifen agonist activity in glioblastoma cells. Qu C; Ma J; Zhang Y; Han C; Huang L; Shen L; Li H; Wang X; Liu J; Zou W Cancer Sci; 2019 Jan; 110(1):221-234. PubMed ID: 30417588 [TBL] [Abstract][Full Text] [Related]
17. A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells. Zhang XT; Kang LG; Ding L; Vranic S; Gatalica Z; Wang ZY Oncogene; 2011 Feb; 30(7):770-80. PubMed ID: 20935677 [TBL] [Abstract][Full Text] [Related]
18. ER-α36-mediated rapid estrogen signaling positively regulates ER-positive breast cancer stem/progenitor cells. Deng H; Zhang XT; Wang ML; Zheng HY; Liu LJ; Wang ZY PLoS One; 2014; 9(2):e88034. PubMed ID: 24558373 [TBL] [Abstract][Full Text] [Related]
19. ER-α36 mediates estrogen-stimulated MAPK/ERK activation and regulates migration, invasion, proliferation in cervical cancer cells. Sun Q; Liang Y; Zhang T; Wang K; Yang X Biochem Biophys Res Commun; 2017 Jun; 487(3):625-632. PubMed ID: 28435071 [TBL] [Abstract][Full Text] [Related]
20. let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer. Zhao Y; Deng C; Lu W; Xiao J; Ma D; Guo M; Recker RR; Gatalica Z; Wang Z; Xiao GG Mol Med; 2011; 17(11-12):1233-41. PubMed ID: 21826373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]